Expression of small, therapeutic RNAs in human cell nuclei

Gene Therapy

Volumn 4, Issue 1, 1997, Pages 45-54

  Good, P D ^a   Krikos, A J ^a   Li, S X L ^b   Bertrand, E ^c   Lee, N S ^c   Giver, L ^d   Ellington, A ^d   Zaia, J A ^b   Rossi, J J ^c   Engelke, D R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INDIANA UNIVERSITY   (United States)

Author keywords

Aptamers; HIV 1; Ribozymes; Small nuclear RNA; U6

Indexed keywords

COMPLEMENTARY RNA; MESSENGER RNA; METHIONINE TRANSFER RNA; REV PROTEIN; RIBOZYME; RNA BINDING PROTEIN; RNA DIRECTED DNA POLYMERASE; SMALL NUCLEAR RNA; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA TRANSFECTION; GENE CASSETTE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROMOTER REGION; PROVIRUS; RNA CAPPING; RNA SEQUENCE; RNA TRANSCRIPTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 8044253998     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300354     Document Type: Article

References (42)

1. Rittner K, Sczakiel G. Identification and analysis of antisense RNA target regions of the human immunodeficiency virus type 1. Nucleic Acids Res 1991; 19: 1421-1426.
2. Castanotto D, Rossi JJ, Deshler JO. Biological and functional aspects of catalytic RNAs. Crit Rev Eukaryotic Gen Exp 1992; 2:331-357.
3. Elkins DA, Rossi JJ. Cellular delivery of ribozymes. In: Delivery Strategies for Antisense Oligonucleotide Therapeutics. Akhtar S (ed). CRC Press. Boca Raton, 1995.
4. Rossi JJ. Practical ribozymes. Making ribozymes work in cells. Curr Biol 1994; 4:469-471.
5. Rossi JJ, Sarver N. RNA enzymes (ribozymes) as antiviral therapeutic agents. TIBTECH 1990; 8:179-183.
6. Stull RA, Szoka FC Jr. Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects. Pharm Res 1995; 12:465-483.
7. Yu M, Poeschla E, Wong-Staal F. Progress towards gene therapy for HIV infection. Gene Therapy 1994; 1:13-26.
8. Gold L, Polisky B, Uhlenbeck O, Yarus M. Diversity of oligonucleotide functions. Annu Rev Biochem 1995; 64:763-797.
9. Lee SW, Gallardo HF, Gilboa E, Smith C. Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain. J Virol 1994; 68: 8254-8264.
10. Sullenger BA, Gallardo HF, Ungers GE, Gilboa E. Over-expression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 1990; 63:601-608.
11. Sullenger BA, Gallardo HF, Ungers GE, Gilboa E. Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation. J Virology 1991; 65: 6811-6816.
12. Sullenger BA, Cech TR. Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA. Science 1993; 262: 1566-1569.
13. Danzeiser DA, Urso O, Kunkel GR. Functional characterization of elements in a human U6 small nuclear RNA gene distal control region. Mol Cell Biol 1993; 13: 4670-4678.
14. Kunkel GR, Maser RL, Calvet JP, Pederson C. U6 small nuclear RNA is transcribed by RNA polymerase III. Proc Natl Acad Sci USA 1986; 83: 8575-8579.
15. Kunkel GR, Pederson T Transcription of a human U6 small nuclear RNA gene in vivo withstands deletion of intragenic sequences but not of an upstream TATATA box. Nucleic Acids Res 1989; 17:7371-7379.
16. Noonberg SB et al. In vivo generation of highly abundant sequence-specific oligonucleotides for antisense and triplex gene regulation. Nucleic Acids Res 1994; 22: 2830-2836.
17. I. Cell 1986; 44:391-400.
18. Timmappaya B, Weinberger C, Schneider RJ, Shenk J. Adenovirus VAI RNA is required for efficient translation of viral mRNA at late times after infection. Cell 1982; 31:543-551.
19. Adeniyi-Jones S, Romeo PH, Zasloff M. Generation of long read-through transcripts in vivo and in vitro by deletion of 3′ termination and processing sequences in the human tRNAimet gene. Nucleic Acids Res 1984; 12: 1101-1115.
20. Ojwang JO et al. Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme. Proc Natl Acad Sci USA 1992; 89: 10802-10806.
21. Thompson JD et al. Improved accumulation and activity of ribozymes expressed from a tRNA-based RNA polymerase III promoter. Nucleic Acids Res 1995; 23: 2259-2268.
22. Hayashi K. Organization of sequences related to U6 RNA in the human genome. Nucleic Acids Res 1981; 9: 3379-3389.
23. Weinberg RA, Peuman S. Small molecular weight monodisperse nuclear RNA. J Mol Biol 1968; 38:289-304.
24. Carmo-Fonseca M, Pepperkok R, Carvalho MT, Lamond AI. Transcription-dependent colocalization of U1,U2,U4/U6, and U5 snRNPs in coiled bodies. J Cell Biol 1992; 117:1-14.
25. Andersen J, Zieve GW. Assembly and intracellular transport of snRNP particles. BioEssays 1991; 13:57-64.
26. Hamm J, Darzynkiewicz E, Tahara SM, Mattaj IW. The trimethylguanosine cap structure of U1 snRNA is a component of a bipartite nuclear targeting signal. Cell 1990; 62:569-577.
27. Gupta S, Busch RK, Singh R, Reddy R. Characterization of U6 small nuclear RNA cap-specific antibodies. J Biol Chem 1990; 265: 19137-19142.
28. Shumyatsky G, Wright D, Reddy R. Methylphosphate cap structure increases the stability of 7SK, B2 and U6 small RNAs in Xenopus oocytes. Nucleic Acids Res 1993; 21: 4756-4761.
29. Singh R, Gupta S, Reddy R. Capping of mammalian U6 small nuclear RNA in vitro is directed by a conserved stem-loop and AUAUAC sequence: conversion of a noncapped RNA into a capped RNA. Mol Cell Biol 1990; 10:939-946.
30. Yu M et al. A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1993; 90: 6340-6344.
31. Yamada O et al. Intracellular immunization of human T cells with a hairpin ribozyme against human immunodeficiency virus type 1. Gene Therapy 1994; 1:38-45.
32. Tuerk C, MacDougal-Waugh S. In vitro evolution of functional nucleic acids: high-affinity RNA ligands of HIV-1 proteins. Gene 1993; 137:33-39.
33. Giver L et al. Selective optimization of the Rev-binding of HIV-1. Nucleic Acids Res 1993; 21: 5509-5516.
34. Jimenez-Garcia LF, Spector DL. In vivo evidence that transcription and splicing are coordinated by a recruiting mechanism. Cell 1993; 73:47-59.
35. Symensma T et al. RNA aptamers selected to bind human immunodeficiency virus type 1 Rev in vitro are Rev responsive in vivo. J Virol 1996; 70:179-187.
36. Bertrand E et al. Development of expression cassettes and viral vectors for expression of ribozyme and antisense RNAs in mammalian cells. RNA (in press).
37. Kunkel GR, Pederson T. Upstream elements required for efficient transcription of a human U6 RNA gene resemble those of U1 and U2 genes even though a different polymerase is used. Genes Dev 1988; 2: 196-204.
38. Sanes JR, Rubenstein JLR, Nicolas J-F. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J 1986; 5: 3133-3142.
39. Köhrer K, Domdey H. Preparation of high molecular weight RNA. Meth Enzymol 1991; 194:399-415.
40. Mertz LM, Westfall B, Rashtchian A. PCR nonradioactive labeling system for synthesis of biotinylated DNA probes. Focus 1995; 16:49-51.
41. Wigler M, Pellicer A, Silverstein S, Axel R. Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor. Cell 1978; 14:725-731.
42. Goldstein S et al. Detection of SIV antigens by HIV-1 antigen capture immunoassays. J Acquir Immun Def Syndr 1990; 3:98-102.